DENISE THOMAS: Open Payments
NPI 1821498239 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 108 payments from 11 companies in 2025. Trend: 2023 $844 · 2024 $1,295 · 2025 $2,050
Food & beverage: $2,050
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $623 |
| Madrigal Pharmaceuticals | 11 | $423 |
| Phathom Pharmaceuticals, Inc. | 18 | $254 |
| Janssen Biotech, Inc. | 14 | $249 |
| Lilly USA, LLC | 10 | $183 |
| Gilead Sciences, Inc. | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
| Ardelyx, Inc. | 4 | $66 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: REZDIFFRA, VOQUEZNA, TREMFYA, RINVOQ, OMVOH, SKYRIZI, CREON, LINZESS.
Industry payments across AL — which companies pay providers there.
